Metabolic Syndrome in Patients With Coronary Heart Disease. Results of Using Different Diagnostic Criteria

• Published in: Revista española de cardiologia Vol. 57; no. 9; pp. 889 - 893
• Main Authors: Hernández Mijares, Antonio, Riera Fortuny, Concepción, Martínez Triguero, María L., Morillas Ariño, Carlos, Cubells Cascales, Pilar, Morales Suárez-Varela, María
• Format: Journal Article
• Language: English; Spanish
• Published: Spain Elsevier Espana 01-09-2004
• Subjects: Adult; Aged; Blood Chemical Analysis; Coronary Disease - blood; Coronary Disease - complications; Coronary Disease - epidemiology; Cross-Sectional Studies; Diabetes mellitus; Factores de riesgo; Female; Hiperlipoproteinemia; Hipertensión arterial sistémica; Humans; Hyperlipoproteinemia; Male; Metabolic Syndrome - blood; Metabolic Syndrome - complications; Metabolic Syndrome - epidemiology; Middle Aged; Obesidad; Obesity; Risk factors; Systemic hypertension; Hiperlipoproteinemia; Obesity; Obesidad; Systemic hypertension; Hipertensión arterial sistémica; Diabetes mellitus; Hyperlipoproteinemia; Factores de riesgo; Risk factors
• ISSN: 1885-5857; 0300-8932; 1885-5857
• DOI: 10.1016/S1885-5857(06)60655-5

A unified definition of metabolic syndrome, considered a common feature of cardiovascular risk, is lacking. The aim of this study was to compare the prevalence of this syndrome in patients with ischemic heart disease using two diagnostic criteria: the European Group of Resistance to Insulin and the National Cholesterol Education Program. We designed an observational, cross-sectional study of the factors that make up metabolic syndrome in subjects diagnosed with coronary heart disease.
A total of 169 patients aged 35 to 79 years were studied (129 men and 40 women). With the European group criterion the percentage of patients with metabolic syndrome was 43.7%, whereas the American group criterion yielded a prevalence of 40.8% (no significant difference). The prevalence of metabolic syndrome among patients with ischemic heart disease is high. The diagnostic criteria used are similar and do not differ significantly, although diagnostic concordance was only 50%.
Carecemos de un criterio único para definir el síndrome metabólico, considerado como aglutinador del riesgo cardiovascular. Con objeto de comparar su prevalencia en pacientes con cardiopatía isquémica, utilizando los criterios del Grupo Europeo de Resistencia a la Insulina y los del National Colesterol Education Program, se diseñó un estudio observacional, transversal, de los factores integrantes del síndrome metabólico en pacientes con cardiopatía isquémica.
Se estudió a 169 pacientes (129 varones y 40 mujeres) con edades entre 35 y 79 años. La prevalencia del síndrome metabólico con los criterios del grupo europeo fue del 43,7% y con los del grupo americano, del 40,8% (sin diferencias significativas). La prevalencia del síndrome metabólico entre pacientes con cardiopatía isquémica es elevada. Los criterios diagnósticos utilizados son similares y sin diferencias significativas entre ellos, aunque la concordancia diagnóstica fue del 50%.